Lisata Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lisata Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Lisata Therapeutics Inc
Rating: 1.41308325
Author: Trendlyne DVM scores

about

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

2.32 -0.03 (-1.28%)

44.76% Fall from 52W High

32,806

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.3 / 100

Technically Neutral

38.2 / 100

1Yr Price target upside is 791%

3 analysts

Lisata Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lisata Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

44.76% Fall from 52W High

SWOT Analysis

Lisata Therapeutics Inc Live Price Chart